Innate Pharma S.A. Analysis
| Analyst Ratings |
|
Average Target Price
|
8.01
|
|
Average Rating
|
4.40
|
|
# Strong Buys
|
3
|
|
# Buys
|
1
|
|
# Holds
|
1
|
|
# Sells
|
0
|
|
# Strong Sells
|
0
|
| Quarterly Earnings History |
| Quarter |
EPS Estimate |
EPS Actual |
EPS Difference |
Surprise Percent |
|
2022-12-31
|
-0.39
|
0.00
|
0.39
|
100.00%
|
|
2022-09-30
|
0.00
|
0.00
|
0.00
|
0.00%
|
|
2022-06-30
|
-0.08
|
0.00
|
0.08
|
100.00%
|
|
2022-03-31
|
0.00
|
0.00
|
0.00
|
0.00%
|
|
2021-12-31
|
0.00
|
-0.66
|
-0.66
|
0.00%
|
|
2021-09-30
|
0.00
|
0.00
|
0.00
|
0.00%
|
|
2021-06-30
|
0.00
|
0.00
|
0.00
|
0.00%
|
|
2021-03-31
|
0.00
|
-0.18
|
-0.18
|
0.00%
|
| Annual Earnings History |
| Fiscal Year End |
EPS |
|
2022-12-31
|
0.00
|
|
2021-12-31
|
-0.84
|
|
2020-12-31
|
-0.43
|
|
2019-12-31
|
-0.22
|
|
2018-12-31
|
0.08
|